Corbus Pharmaceuticals Holdings (CRBP) Income from Continuing Operations (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded Income from Continuing Operations of -$23.29 million in Q3 2025, compared with -$13.98 million a year earlier.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Income from Continuing Operations (2013 - 2025) Analysis & Trends
On a TTM basis, Corbus Pharmaceuticals Holdings' Income from Continuing Operations came in at -$70.05 million as of Sep 30, 2025; for FY2024, it was -$44.28 million.
- Across earlier years, Income from Continuing Operations came in at -$47.3 million in FY2023, -$39.84 million in FY2022, -$55.99 million in FY2021 and -$122.81 million in FY2020.
- The Q3 2025 figure is the lowest quarterly Income from Continuing Operations since Q3 2020.
- Per Business Quant, the preceding three quarters came in at -$17.84 million (Q2 2025), -$18.09 million (Q1 2025) and -$10.83 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 52.74 Mn | -463.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -23.29 Mn |
| Jun 30, 2025 | -17.84 Mn |
| Mar 31, 2025 | -18.09 Mn |
| Dec 31, 2024 | -10.83 Mn |
| Sep 30, 2024 | -13.98 Mn |
| Jun 30, 2024 | -10.04 Mn |
| Mar 31, 2024 | -9.43 Mn |
| Dec 31, 2023 | -11.03 Mn |
| Sep 30, 2023 | -10.47 Mn |
| Jun 30, 2023 | -9.20 Mn |
| Mar 31, 2023 | -17.30 Mn |
| Dec 31, 2022 | -10.80 Mn |
| Sep 30, 2022 | -8.18 Mn |
| Jun 30, 2022 | -12.34 Mn |
| Mar 31, 2022 | -8.52 Mn |
| Dec 31, 2021 | -10.00 Mn |
| Sep 30, 2021 | -13.88 Mn |
| Jun 30, 2021 | -16.70 Mn |
| Mar 31, 2021 | -15.41 Mn |
| Dec 31, 2020 | -20.81 Mn |
API Access
Corbus Pharmaceuticals Holdings Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();